Literature DB >> 34055183

Primary Eccrine Adenocarcinoma: A Rare but Dangerous Lesion of the Eyelid.

John Awad1, David Cheung1.   

Abstract

Sweat gland carcinomas can be of eccrine or apocrine origin, with the former being more common in the eyelid. They can also be of three different types, the most common of which is mucin-producing sweat gland carcinoma, which is most often a low-grade malignancy. Here, we report a case of a primary estrogen receptor-positive eccrine adenocarcinoma of the eyelid that clinically presented like a cyst of Moll. Importantly, in our experience with this lesion, this rare malignancy was repeatedly misdiagnosed as less sinister lesions, surgical resection margins of the lesion could be easily underestimated, and close liaison with our general surgical colleagues was vital to exclude more common breast carcinoma. This case highlights the dangers of referral recommendation policies (e.g., procedures of limited clinical value as used by primary care) and the importance of incisional biopsy in the management of periocular lesions.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Cyst of Moll; eyelid lesion; sweat gland carcinoma

Year:  2021        PMID: 34055183      PMCID: PMC8142825     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  9 in total

1.  Primary signet ring cell carcinoma of the eyelid in a young woman.

Authors:  R Khoramnia; C Mayer; E Glaser; G Weirich
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

2.  Metastatic eyelid carcinoma.

Authors:  A C Arnold; J D Bullock; R Y Foos
Journal:  Ophthalmology       Date:  1985-01       Impact factor: 12.079

Review 3.  Mucinous sweat gland adenocarcinoma of the eyelid - current knowledge of a rare tumor.

Authors:  Avichai Segal; Nili Segal; Andrew Gal; Krishna Tumuluri
Journal:  Orbit       Date:  2010-12

Review 4.  Signet ring cell carcinoma of the eccrine sweat glands in the eyelid.

Authors:  G Wollensak; H Witschel; N Böhm
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

Review 5.  Signet-ring cell/histiocytoid carcinoma of the eyelid: a case report and review of the literature.

Authors:  Jantima Tanboon; Monkol Uiprasertkul; Panitee Luemsamran
Journal:  Am J Dermatopathol       Date:  2013-02       Impact factor: 1.533

6.  Primary signet ring cell carcinoma of the eyelid.

Authors:  Jennifer S L Tan; Penelope A McKelvie; Thomas G Hardy
Journal:  Orbit       Date:  2013-09-24

7.  Mohs micrographic surgery in the setting of squamoid eccrine ductal carcinoma: addressing a diagnostic and therapeutic challenge.

Authors:  Shane Clark; Adam Young; Eli Piatigorsky; Larisa Ravitskiy
Journal:  J Clin Aesthet Dermatol       Date:  2013-04

8.  Signet ring cell carcinoma of the eyelid - the monocle tumour.

Authors:  Anouck Leuba Mortensen; Steffen Heegaard; Ole Clemmensen; Jan Ulrik Prause
Journal:  APMIS       Date:  2008-04       Impact factor: 3.205

Review 9.  Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.

Authors:  Matteo Lazzeroni; Davide Serrano; Barbara K Dunn; Brandy M Heckman-Stoddard; Oukseub Lee; Seema Khan; Andrea Decensi
Journal:  Breast Cancer Res       Date:  2012-10-29       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.